Table 2.
Future Areas of Research for Acinetobacter
| Virulence factors |
| Mechanisms of antibiotic resistance |
| Colistin |
| Optimal timing and dosing for intravenous and inhaled |
| Outcome data, including adverse events |
| Role of new and alternative antimicrobials |
| Tigecycline, minocycline, rifampicin |
| Combination therapy |
| Mortality data (attributable and overall) |
| Infection control |